StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $10.00 price target on shares of Pulmatrix in a research note on Tuesday, February […]
StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a research note published on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $10.00 price target on shares of Pulmatrix in a report on Tuesday, February 7th. Pulmatrix […]
Pulmatrix, Inc. (NASDAQ:PULM – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 3,700 shares, an increase of 184.6% from the April 30th total of 1,300 shares. Approximately 0.1% of the shares of the stock are short sold. […]
StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a research note released on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $10.00 price objective on shares of Pulmatrix in a research note on Tuesday, February 7th. Pulmatrix […]
Pulmatrix (NASDAQ:PULM – Get Rating) announced its earnings results on Friday. The biotechnology company reported ($1.22) EPS for the quarter, reports. The business had revenue of $1.50 million during the quarter. Pulmatrix had a negative net margin of 310.26% and a negative return on equity of 51.32%. Pulmatrix Stock Performance PULM traded down $0.14 during […]